Schonfeld Strategic Advisors LLC Caribou Biosciences, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 2,351,582 shares of CRBU stock, worth $3.64 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,351,582
Previous 2,113,272
11.28%
Holding current value
$3.64 Million
Previous $3.36 Million
36.34%
% of portfolio
0.01%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding CRBU
# of Institutions
137Shares Held
47MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$7.01 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.27MShares$5.07 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$3.88 Million0.18% of portfolio
-
Geode Capital Management, LLC Boston, MA2.05MShares$3.18 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $94.3M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...